Infection, delayed kidney function, kidney loss and death are all risks associated with kidney transplant surgery in obese ...

A 68-week phase 3 trial found that coadministered cagrilintide and semaglutide led to significant and clinically meaningful ...

The study revealed the physiological and pathophysiological functions of a novel microbial-derived amino acid-conjugated bile acid, tryptophan-cholic acid (Trp-CA). It identified the membrane receptor ...

Atrogi's breakthrough discovery enables chronic use of next-generation, highly selective β2-agonists for the first time in metabolic disease ...

Participants in the 72-week STEP UP trial who received the increased Wegovy dose of 7.2 mg experienced a mean weight reduction of 21%, while a third of them reached 25% body weight loss. Adults with ...

DelveInsight's Sarcopenia Market Insights report includes a comprehensive understanding of current treatment practices, ...

In a rodent model of type 2 diabetes (T2D), icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and b ...

U.S. pharma companies should pay rather more of their corporate income tax in the U.S.—and start producing more of their best drugs in the U.S. as well.

With weight-loss injections like Semaglutide gaining popularity, experts warn they’re not a one-size-fits-all fix. We got in touch with an expert who explains why long-term success lies in combining ...

In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming ...